CTI BioPharma Corp. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
71,639.00
70,933.00
128,204.00
44,015.50
43,218.00
67,038
Total Accounts Receivable
335.00
2,211.00
782.00
8,456.00
1,382.00
13,679
Inventories
5,074.00
4,182.00
2,845.00
1,525.00
550.00
-
Other Current Assets
3,467.00
3,179.00
3,144.00
1,827.50
1,774.00
1,775
Total Current Assets
80,515.00
80,505.00
134,975.00
55,824.00
46,924.00
82,492
Net Property, Plant & Equipment
5,478.00
4,646.00
3,718.00
3,023.00
2,365.00
1,793
Long-Term Note Receivable
5,600.00
4,700.00
4,700.00
4,400.00
4,700.00
4,480
Other Assets
2,130.00
2,436.00
804.00
596.00
897.00
1,067
Total Assets
93,723.00
92,287.00
144,197.00
63,843.00
54,886.00
89,832
ST Debt & Current Portion LT Debt
3,155.00
9,014.00
37,371.00
7,949.00
444.00
Accounts Payable
5,051.00
6,356.00
10,584.00
7,227.00
2,588.00
Other Current Liabilities
11,863.00
20,970.00
24,454.00
25,470.00
16,226.00
Total Current Liabilities
20,069.00
36,340.00
72,409.00
40,646.00
19,258.00
Long-Term Debt
10,152.00
8,363.00
19,124.00
11,311.00
13,575.00
Other Liabilities
7,283.00
7,661.00
5,251.00
4,129.00
5,963.00
Total Liabilities
37,504.00
52,364.00
96,784.00
56,086.00
38,796.00
Common Equity (Total)
45,173.00
41,755.00
52,031.00
13,319.00
20,723.00
Total Shareholders' Equity
45,173.00
41,755.00
52,031.00
13,319.00
21,813.00
Total Equity
42,758.00
38,478.00
47,413.00
7,757.00
16,090.00
Liabilities & Shareholders' Equity
93,723.00
92,287.00
144,197.00
63,843.00
54,886.00
Accumulated Minority Interest
2,415.00
3,277.00
4,618.00
5,562.00
5,723.00
Non-Equity Reserves
13,461.00
1,445.00
-
-
-
Preferred Stock (Carrying Value)
-
-
-
-
1,090.00
About CTI BioPharma
View Profile
